Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

M. Duruisseaux; Anna Martínez‐Cardús; María Eréndira Calleja-Cervantes; Sebastián Morán; Manuel Castro de Moura; Verónica Dávalos; David Piñeyro; Montse Sánchez‐Céspedes; Nicolas Girard; Marie Brevet; Etienne Giroux‐Leprieur; Coraline Duménil; Monica Pradotto; Paolo Bironzo; Enrica Capelletto; Silvia Novello; Alexis B. Cortot; Marie‐Christine Copin; Niki Karachaliou; María González‐Cao; Sergio Peralta; Luis M. Montuenga; Ignacio Gil‐Bazo; Iosune Baraibar; María D. Lozano; Mar Varela; J.C. Ruffinelli; Ramón Palmero; Ernest Nadal; Teresa Morán; L.Mezquita Pérez; Immaculada Ramos; Qingyang Xiao; Agustín F. Fernández; Mario F. Fraga; Marta Gut; Marta Gut; Cristina Teixidó; Noelia Vilariño; Aleix Prat; Noemı́ Reguart; Amparo Benito; Pilar Garrido; Isabel Barragán; Jean‐François Emile; Rafael Rosell; Élisabeth Brambilla; Manel Esteller

doi:10.1016/s2213-2600(18)30284-4

Related publications

Article2022

Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas, Valerio Iebba, Gérard Zalcman, S. Friard, Julien Mazières, Clarisse Audigier-Valette, Denis Moro‐Sibilot, François Goldwasser, Carolina Alves Costa Silva, Safae Terrisse, Mélodie Bonvalet, Arnaud Scherpereel, Hervé Pegliasco, Corentin Richard, François Ghiringhelli, Arielle Elkrief, Antoine Desîlets, Félix Blanc‐Durand, Fabio Cumbo, Aitor Blanco‐Míguez, Romain Boidot, Sandy Chevrier, Romain Daillère, Guido Guido Kroemer, Laurie Alla, Nicolas Pons, Emmanuelle Le Chatelier, Nathalie Galleron, Hugo Roume, Agathe Dubuisson, Nicole Bouchard, Meriem Messaoudene, Damien Drubay, Éric Deutsch, Fabrice Barlési, David Planchard, Nicola Segata, Stéphanie Martinez, Laurence Zitvogel, Jean‐Charles Soria, Benjamin Besse

Article2016

Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis

Sebastián Morán, Anna Martínez‐Cardús, Sergi Sayols, Eva Musulén, Carmen Balañá, Anna Estival-Gonzalez, Cátia Moutinho, Holger Heyn, Ángel Díaz‐Lagares, Manuel Castro de Moura, Giulia Maria Stella, Paolo M. Comoglio, María Ruiz-Miró, Xavier Matías‐Guiu, Roberto Pazo-Cid, Antonio Antón, Rafael López‐López, G. Soler, Federico Longo, Isabel Guerra, Sara Gutiérrez Fernández, Yassen Assenov, Christoph Plass, Rafael Morales,

Editorial Material2021

Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade

Guido Guido Kroemer, Oliver Kepp

Article2021

Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study

Inês Pires da Silva, Tasnia Ahmed, Irene L. M. Reijers, Alison M. Weppler, Allison Betof Warner, James R. Patrinely, Patricio Serra-Bellver, Clara Allayous, Joanna Mangana, Khang Nguyen, Lisa Zimmer, Claudia Trojaniello, Dan Stout, Megan Lyle, Oliver Klein, Camille L. Gérard, Olivier Michielin, Andrew Haydon, Paolo A. Ascierto, Matteo S. Carlino, Célèste Lebbé, Paul Lorigan,

Article2018

Abstract LB-121: Exploring the germ-line contribution to exceptional response to PD-1/PD-L1 inhibition in patients with metastatic non-small-cell lung cancer by whole genome sequencing

Megan Barnet, Katherine Jackson, Bo Gao, Adnan Nagrial, Michael Boyer, Wendy A. Cooper, Rina Hui, Anthony Linton, Martin H.N. Tattersall, Greg Gibson, Jonathan Cebon, Georgina V. Long, Alexander M. Menzies, Richard A Scolyer, Paul Lacaze, Robert Brink, Timothy J. Peters, Mark J. Cowley, Velimir Gayevskiy, David M. Thomas, Mark Pinese,